A detailed history of Kathmere Capital Management, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Kathmere Capital Management, LLC holds 6,190 shares of ZTS stock, worth $1.09 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
6,190
Previous 5,317 16.42%
Holding current value
$1.09 Million
Previous $921,000 31.27%
% of portfolio
0.12%
Previous 0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$172.58 - $196.48 $150,662 - $171,527
873 Added 16.42%
6,190 $1.21 Million
Q2 2024

Jul 17, 2024

BUY
$145.54 - $178.83 $153,108 - $188,129
1,052 Added 24.67%
5,317 $921,000
Q2 2024

Jul 01, 2024

BUY
$145.54 - $178.83 $16,009 - $19,671
110 Added 2.65%
4,265 $739,000
Q1 2024

Apr 16, 2024

SELL
$165.67 - $199.94 $18,223 - $21,993
-110 Reduced 2.58%
4,155 $703,000
Q4 2023

Apr 16, 2024

BUY
$151.44 - $200.09 $1,665 - $2,200
11 Added 0.26%
4,265 $841,000
Q3 2023

Oct 11, 2023

BUY
$167.14 - $192.77 $120,675 - $139,179
722 Added 20.44%
4,254 $740,000
Q2 2023

Jul 11, 2023

SELL
$160.94 - $186.23 $19,151 - $22,161
-119 Reduced 3.26%
3,532 $608,000
Q1 2023

Apr 20, 2023

BUY
$145.48 - $175.02 $253,280 - $304,709
1,741 Added 91.15%
3,651 $607,000
Q4 2022

Jan 24, 2023

SELL
$131.14 - $157.47 $49,964 - $59,996
-381 Reduced 16.63%
1,910 $0
Q4 2022

Jan 24, 2023

BUY
$131.14 - $157.47 $300,441 - $360,763
2,291 New
2,291 $0
Q2 2022

Aug 09, 2022

BUY
$155.97 - $200.09 $244,249 - $313,340
1,566 New
1,566 $269,000
Q1 2021

May 07, 2021

SELL
$144.0 - $169.39 $9,216 - $10,840
-64 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$157.07 - $174.35 $10,052 - $11,158
64 New
64 $11,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Kathmere Capital Management, LLC Portfolio

Follow Kathmere Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kathmere Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kathmere Capital Management, LLC with notifications on news.